Stay updated on TAK-861 in Narcolepsy Type 1 Clinical Trial
Sign up to get notified when there's something new on the TAK-861 in Narcolepsy Type 1 Clinical Trial page.

Latest updates to the TAK-861 in Narcolepsy Type 1 Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded a site revision note (Revision: v3.4.2) and removed an older funding-status notice; no study-specific content, eligibility criteria, or results were changed.SummaryDifference0.3%

- Check21 days agoChange DetectedAdded a site-wide notice about government funding lapse and updated operating status guidance, and updated the revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check28 days agoChange DetectedAdded Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0; removed Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check35 days agoChange DetectedThe page revision updated from v3.3.3 to v3.3.4. No substantive study data, criteria, outcomes, contacts, or locations were changed; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check43 days agoChange DetectedPublication citation in the Publications section was updated: the JAMA Neurology article on Oveporexton now appears with the e254825 online-ahead-of-print identifier, replacing the previous pagination.SummaryDifference0.0%

- Check64 days agoChange DetectedNew study sites were added across several regions (US, Europe, Australia, and Asia) and many locations were removed. The page revision indicates Revision: v3.3.3.SummaryDifference3%

Stay in the know with updates to TAK-861 in Narcolepsy Type 1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TAK-861 in Narcolepsy Type 1 Clinical Trial page.